SageView Advisory Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.02M Sell
19,763
-1,378
-7% -$321K 0.16% 84
2026
Q1
$5.17M Sell
21,141
-7,989
-27% -$1.86M 0.19% 68
2025
Q4
$6.03M Sell
29,130
-1,034
-3% -$204K 0.2% 62
2025
Q3
$5.59M Buy
30,164
+8,453
+39% +$1.45M 0.19% 68
2025
Q2
$3.61M Buy
21,711
+205
+1% +$31.5K 0.14% 89
2025
Q1
$3.57M Buy
21,506
+4,061
+23% +$635K 0.15% 77
2024
Q4
$2.52M Buy
17,445
+6,778
+64% +$1.05M 0.11% 105
2024
Q3
$1.73M Sell
10,667
-7,132
-40% -$1.14M 0.09% 128
2024
Q2
$2.6M Buy
+17,799
New +$2.65M 0.12% 104
2024
Q1
Sell
-19,359
Closed -$3.07M 639
2023
Q4
$3.07M Buy
19,359
+9,597
+98% +$1.47M 0.13% 97
2023
Q3
$1.52M Sell
9,762
-196
-2% -$32.3K 0.09% 140
2023
Q2
$1.65M Buy
9,958
+880
+10% +$142K 0.09% 139
2023
Q1
$1.41M Buy
9,078
+509
+6% +$82.2K 0.09% 154
2022
Q4
$1.51M Buy
+8,569
New +$1.48M 0.12% 118

Other funds holding JNJ

SageView Advisory Group's JNJ Position: Q2 2026 in Review

SageView Advisory Group reduced its Johnson & Johnson (JNJ) stake by 6.5% in Q2 2026, selling an estimated $321K and leaving 19,763 shares worth $5.02M. The position accounts for 0.16% of the portfolio, ranked #84.

SageView Advisory Group first reported a position in JNJ in Q4 2022 and has held it in 14 quarters since. The position peaked at $6.03M in Q4 2025. 4,689 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • SageView Advisory Group held 19,763 shares of Johnson & Johnson worth $5.02M as of Q2 2026.
  • SageView Advisory Group sold 1,378 Johnson & Johnson shares in Q2 2026, an estimated $321K.
  • Johnson & Johnson made up 0.16% of SageView Advisory Group's portfolio in Q2 2026, its #84 holding.
  • SageView Advisory Group first reported a position in Johnson & Johnson in Q4 2022 and has held it in 14 quarters since.
  • SageView Advisory Group's Johnson & Johnson position peaked at $6.03M in Q4 2025.
  • 4,689 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on SageView Advisory Group's 13F filing for Q2 2026, filed 10 Aug 2026.